Skip to Content Facebook Feature Image

Waters Sets Benchmark for Standardized Spectral Flow Cytometry with Commercial Launch of BD FACSDiscover A7 Cell Analyzer

Business

Waters Sets Benchmark for Standardized Spectral Flow Cytometry with Commercial Launch of BD FACSDiscover A7 Cell Analyzer
Business

Business

Waters Sets Benchmark for Standardized Spectral Flow Cytometry with Commercial Launch of BD FACSDiscover A7 Cell Analyzer

2026-09-14 20:00 Last Updated At:20:15

  • Enables routine 50+ parameter experiments with BD SpectralFX™ Technology, accelerating breakthrough discoveries in the fight against cancer and other diseases.
  • Minimizes instrument and user differences with first-of-its-kind FACSTruQ™ Technology, achieving industry-leading standardization for greater confidence in results.
  • Integrated autoloader and BD FACSChorus™ Software speeds time to insight for new and experienced users.

MILFORD, Mass., Sept. 14, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today announced the global commercial launch of the BD FACSDiscover™ A7 Cell Analyzer, which uniquely combines exceptional spectral resolution and sensitivity with industry-leading standardization and ease-of-use features, making the power of advanced flow cytometry more accessible to researchers in academia and pharmaceutical settings, as well as in contract research organization (CRO) labs.

The new cell analyzer expands Waters' category-defining FACSDiscover platform of flow cytometers, incorporating the same cutting-edge BD SpectralFX Technology present in the flagship BD FACSDiscover A8 Cell Analyzer, which supports up to five lasers and 78 fluorescence detectors to maximize the palette of colors. This technology enables scientists to analyze more than 50 characteristics of a single cell with consistent, high-quality data.

Together with FACSTruQ Technology, a notable product innovation that delivers next-generation instrument calibration with automated setup and quality control, the cell analyzer provides data consistency across instruments, users, and sites, achieving highly reproducible results with a less than 10% coefficient of variation across a palette of more than 50 dyes.1 Paired with the BD FACSChorus Software's guided workflows and the integrated autoloader, the FACSDiscover A7 Cell Analyzer sets a new standard for experimental standardization in flow cytometry.

"The FACSDiscover A7 Cell Analyzer lowers the barrier to advanced spectral flow cytometry and will open up new possibilities for immunology research, enabling our core facility to help scientists uncover deeper biological insights with greater standardization and confidence," said Cheryl Kim, Senior Director, Flow Cytometry Core, La Jolla Institute for Immunology. "We look forward to the FACSDiscover A7 Cell Analyzer being an integral instrument for our core, allowing our researchers to get the most out of spectral data to advance our important work of improving human health through the development of treatments and cures for immune system disorders."

Steve Conly, Senior Vice President, Waters Biosciences, Waters Corporation, added, "The FACSDiscover A7 Cell Analyzer couples advanced spectral performance and leading standardization with a compelling price-to-performance balance, bringing spectral flow cytometry within reach of more researchers than ever before, for applications from biomarker discovery to drug development. Just two years after the world's very first 50-color flow cytometry panel was developed on the BD FACSDiscover™ S8 Cell Sorter,2 the FACSDiscover A7 Cell Analyzer extends these transformative capabilities, helping labs meet their increasingly critical needs for reproducibility within our connected ecosystem of instruments, reagents, and informatics."

The FACSDiscover A7 Cell Analyzer is now commercially available globally and available to order through local representatives. For more information, please visit waters.com and bdbiosciences.com/A7.

BD is a trademark of Becton, Dickinson and Company. Waters is a trademark of Waters Corporation or its affiliates.  All other marks are the property of their respective owners.

About Waters Corporation:

Waters Corporation (NYSE: WAT) is a global leader in life sciences and diagnostics, dedicated to accelerating the benefits of pioneering science through analytical technologies, informatics, and service. With a focus on regulated, high-volume testing environments, our innovative portfolio harnesses deep scientific expertise across chemistry, physics, and biology. We collaborate with customers around the world to advance the release of effective, high-quality medicines, ensure the safety of food and water, and drive better patient outcomes by detecting diseases earlier, managing routine infections, and combating antibiotic resistance. Through a shared culture of relentless innovation, our passionate team of ~15,000 colleagues turn scientific challenges into breakthroughs that improve lives worldwide. For more information, please visit www.waters.com/about.

Disclaimer:

The BD Biosciences and BD Diagnostic Solutions businesses have been acquired by Waters Corporation ("Waters"). Becton, Dickinson and Company or one of its affiliates or subsidiaries ("BD") remains the legal manufacturer of Biosciences and Diagnostic Solutions products until all required regulatory transfers are completed. During this interim period, BD maintains full responsibility for all regulatory obligations of the legal manufacturer. Product information provided here is supplied under BD's regulatory authority. To learn more about the relationship between Waters and BD during this transition period, please see our detailed summary: www.waters.com/bdtransaction.

References:

1) Internal Waters data comparing the BD FACSDiscover™ A7 Cell Analyzer with the BD FACSLyric™ Flow Cytometry System and publicly available data for comparable instruments.

2) Konecny AJ, Mage PL, Tyznik AJ, Prlic M and Mair F. OMIP-102: 50-color phenotyping of the human immune system with in-depth assessment of T cells and dendritic cells. Cytometry Part A 2024; 105:430-436. DOI: 10.1002/cyto.a.24841 

Contact:

Molly Gluck
Head of External Communications
Waters Corporation
+1.508.498.9732
molly_gluck@waters.com

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

Waters Sets Benchmark for Standardized Spectral Flow Cytometry with Commercial Launch of BD FACSDiscover A7 Cell Analyzer

Waters Sets Benchmark for Standardized Spectral Flow Cytometry with Commercial Launch of BD FACSDiscover A7 Cell Analyzer

A global campaign connecting human resilience, global sporting culture and the story of a cycling icon—marking a new chapter in Speediance's evolution as an international sports brand

LOS ANGELES, Sept. 14, 2026 /PRNewswire/ -- On September 12, Speediance, the global smart fitness brand creating connected training experiences for everyday life, named British cycling legend Sir Mark Cavendish KBE its Brand Ambassador and launched "Build for Belief," a global campaign exploring the work behind belief—and the strength it takes to rebuild it.

Founded in 2020, Speediance set out to make world-class training more accessible in everyday life. Today, the brand serves a growing global community and is extending its role beyond smart fitness innovation to build a more meaningful presence in international sporting culture. The appointment of Cavendish marks an important step in that evolution.

Widely regarded as one of cycling's greatest sprinters, Cavendish holds the all-time record for Tour de France stage victories, with 35 wins. His career is defined not only by exceptional speed and sporting achievement, but by longevity, adaptation and the ability to return when others believed the story was over. That makes him more than a symbol of winning: he is living proof of what it takes to rebuild.

The partnership debuts with "Build for Belief," a campaign built around a simple human truth: strength is not about never bending, but about the ability to adapt, rebuild and rise again. Told through a restrained, intimate portrait of Cavendish in training, the film looks beyond race-day victory to the moments that make it possible—five in the morning, the doubt, the weight coming down, and the choice to return, rep after rep and day after day. This spirit reflects the people Speediance is built for: those who see training not as a performance for others, but as a disciplined commitment to becoming stronger than they were yesterday.

The same resolve shapes Speediance itself. The brand pursues excellence through intelligent digital resistance, connected hardware, personalized training and considered industrial design—bringing them together in a precise, professional and progressive training experience. The aim is not to promise belief, but to give people the tools to turn disciplined effort into progress they can measure, own and continue to build upon.

"Globalization is not product distribution; it is the translation of innovation into shared human meaning," said Hongbo Wei, Brand Director at Speediance. "That is why this partnership is more than an ambassador announcement. Through Sir Mark's story, 'Build for Belief' connects technology with human experience, global sporting culture and a belief people everywhere can recognise: strength is built through action, especially when progress is uncertain. It marks Speediance's evolution from explaining what a product does to expressing why training matters in people's lives."

Seen in this way, "Build for Belief" is not simply a celebrity-led campaign. It is a global sports brand narrative shaped by four connected elements: the human experience of doubt and renewal; the cultural language of global sport; the lived story of an athlete who has repeatedly rebuilt; and Speediance's belief that training can help people take ownership of who they are becoming.

To watch "Build for Belief" and learn more, visit: https://www.speediance.com/pages/global-brand-ambassador

The launch also reflects a broader shift in connected fitness. As technology and hardware capabilities advance, product performance remains the foundation of trust—but it is no longer the whole story. The next generation of global fitness brands will be defined not only by how intelligently they help people train, but by whether they can connect that technology to culture, identity and a lasting sense of personal meaning.

BUILD FOR BELIEF. SPEEDIANCE. OWN IT.

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

Speediance Names Cycling Legend Sir Mark Cavendish KBE Brand Ambassador and Launches "Build for Belief"

Speediance Names Cycling Legend Sir Mark Cavendish KBE Brand Ambassador and Launches "Build for Belief"

Recommended Articles